Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTV8N19)

DTT Name Immune checkpoint (ICH)
Gene Name ICH
DTT Type
Clinical trial target
 [1]
UniProt ID
NOUNIPROTAC
TTD ID
T21312

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
2 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
AK107 DM4FOX0 Solid tumour/cancer 2A00-2F9Z Phase 1 [2]
NLG919 DMYPWHD Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Deal watch: Genentech dives deeper into the next wave of cancer immunotherapies. Nat Rev Drug Discov. 2014 Dec;13(12):879.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)